FLT1 and neoplasm: In conclusion, our study demonstrated that VEGFR1+ HPCs and VEGFR2+ EPCs play significant functional roles in tumor progression, and that targeting the host non-tumor VEGFR- expressing cells could inhibit tumor growth, angiogenesis and metastasis.